- Investing Ideas
- /
- U.S. Healthcare Undervalued Small Caps With Insider Buying
U.S. Healthcare Undervalued Small Caps With Insider Buying
Results
3
2 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
3 companies
Tandem Diabetes Care
Market Cap: US$818.3m
Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
New
TNDM
US$12.24
7D
12.4%
1Y
-73.1%
Cerus
Market Cap: US$245.4m
Operates as a biomedical products company.
New
CERS
US$1.33
7D
11.8%
1Y
-42.7%
Accuray
Market Cap: US$174.6m
Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
ARAY
US$1.55
7D
2.6%
1Y
-33.8%